Published in
Oxford University Press, Open Forum Infectious Diseases, 2(11), 2024
DOI: 10.1093/ofid/ofae023
Links
Tools
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures
Journal article published in 2024 by
Paul Thoueille 
,
Matthias Cavassini ,
Monia Guidi ,
Thierry Buclin ,
François R. Girardin,
Laurent A. Decosterd,
Catia Marzolini
,
Matthias Cavassini ,
Monia Guidi ,
Thierry Buclin ,
François R. Girardin,
Laurent A. Decosterd,
Catia Marzolini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 
Abstract
Abstract The interpretation of long-acting cabotegravir and rilpivirine concentrations is complicated by the lack of consensus on the threshold to consider. Building on real-world therapeutic drug monitoring data and documented virologic failures, this article provides a reappraisal of the existing thresholds and guidance for the interpretation of cabotegravir and rilpivirine concentrations.